Related references
Note: Only part of the references are listed.Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1
Chun Yang et al.
GYNECOLOGIC ONCOLOGY (2012)
MicroRNA Signature Distinguishes the Degree of Aggressiveness of Papillary Thyroid Carcinoma
Linwah Yip et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Mutant p53R175H upregulates Twist1 expression and promotes epithelial-mesenchymal transition in immortalized prostate cells
I. Kogan-Sakin et al.
CELL DEATH AND DIFFERENTIATION (2011)
p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2
Taewan Kim et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma
Maria Angeles Castilla et al.
JOURNAL OF PATHOLOGY (2011)
MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1
Peixin Dong et al.
MOLECULAR CANCER (2011)
p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs
Chun-Ju Chang et al.
NATURE CELL BIOLOGY (2011)
miR-130b Promotes CD133+ Liver Tumor-Initiating Cell Growth and Self-Renewal via Tumor Protein 53-Induced Nuclear Protein 1
Stephanie Ma et al.
CELL STEM CELL (2010)
miR-194 Is a Marker of Hepatic Epithelial Cells and Suppresses Metastasis of Liver Cancer Cells in Mice
Zhipeng Meng et al.
HEPATOLOGY (2010)
Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulation
A. R. R. Forrest et al.
LEUKEMIA (2010)
TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs
Xiaohua Su et al.
NATURE (2010)
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
A. Singh et al.
ONCOGENE (2010)
Mutant p53 Gain-of-Function in Cancer
Moshe Oren et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Up-regulation of miR-200 and let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer Cells
Yiwei Li et al.
CANCER RESEARCH (2009)
Breast Cancer Metastasis Suppressor 1 Up-regulates miR-146, Which Suppresses Breast Cancer Metastasis
Douglas R. Hurst et al.
CANCER RESEARCH (2009)
microRNA-451 Regulates Macrophage Migration Inhibitory Factor Production and Proliferation of Gastrointestinal Cancer Cells
Eva Bandres et al.
CLINICAL CANCER RESEARCH (2009)
Elevated expression of p53 gain-of-function mutation R175H in endometrial cancer cells can increase the invasive phenotypes by activation of the EGFR/PI3K/AKT pathway
Peixin Dong et al.
MOLECULAR CANCER (2009)
MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents
Dawn R. Cochrane et al.
MOLECULAR CANCER THERAPEUTICS (2009)
The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
Ulrich Wellner et al.
NATURE CELL BIOLOGY (2009)
Novel Rank-Based Statistical Methods Reveal MicroRNAs with Differential Expression in Multiple Cancer Types
Roy Navon et al.
PLOS ONE (2009)
miR-143 Interferes with ERK5 Signaling, and Abrogates Prostate Cancer Progression in Mice
Cyrielle Clape et al.
PLOS ONE (2009)
p53-Responsive MicroRNAs 192 and 215 Are Capable of Inducing Cell Cycle Arrest
Christian J. Braun et al.
CANCER RESEARCH (2008)
miR-192 Regulates Dihydrofolate Reductase and Cellular Proliferation through the p53-microRNA Circuit
Bo Song et al.
CLINICAL CANCER RESEARCH (2008)
The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2
Manav Korpal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
ZEB1 expression in type I vs type II endometrial cancers:: a marker of aggressive disease
Meenakshi Singh et al.
MODERN PATHOLOGY (2008)
Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer
Lin Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Transcriptional activation of miR-34a contributes to p53-mediated apoptosis
Nina Raver-Shapira et al.
MOLECULAR CELL (2007)
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas
Huban Kutay et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Gain of function of mutant p53: The mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation
Silvia Di Agostino et al.
CANCER CELL (2006)
Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer
YG Xi et al.
CLINICAL CANCER RESEARCH (2006)
Tumor-derived p53 mutants induce NF-κB2 gene expression
MJ Scian et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
MicroRNA expression profiles classify human cancers
J Lu et al.
NATURE (2005)
Direct p53 transcriptional repression:: In vivo analysis of CCAAT-containing G2/M promoters
C Imbriano et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Epithelial-mesenchymal transitions:: Twist in development and metastasis
YB Kang et al.
CELL (2004)
被撤回的出版物: Transactivation of the EGR1 gene contributes to mutant p53 gain of function (Retracted article. See vol. 79, pg. 2085, 2019)
L Weisz et al.
CANCER RESEARCH (2004)
Transcriptional activities of mutant p53: When mutations are more than a loss
E Kim et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Tumor-derived p53 mutants induce oncogenesis by transactivating growth-promoting genes
MJ Scian et al.
ONCOGENE (2004)
Mutant p53 gain of function:: repression of CD95(Fas/APO-1) gene expression by tumor-associated p53 mutants
A Zalcenstein et al.
ONCOGENE (2003)
Mutant p53 forms a complex with Sp1 on HIV-LTR DNA
A Chicas et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Wild type and mutant p53 differentially regulate the gene expression of human collagenase-3 (hMMP-13)
YB Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
